Key result
Surgical removal of a thromboembolic LA mass in a child reveals an inflammatory myofibroblastic tumor.
Why the study?
Cardiac inflammatory myofibroblastic tumors are rare, especially left-sided tumors causing systemic embolism in children.
Case Report (n=1)
This case illustrates a unique presentation of a rare cardiac inflammatory myofibroblastic tumor on the mitral valve causing systemic thromboembolism in a pediatric patient.
Answers are grounded in this paper and cite their sources.
May prompt inclusion of inflammatory myofibroblastic tumor in pediatric cardiac mass differentials; leaves open evidence-based management strategies.
Inflammatory myofibroblastic tumors (IMTs) represent mesenchymal tumors that occur in the lungs, abdomen, or pelvis. Cardiac IMTs are rare, usually right-sided, and when left-sided can cause sudden cardiac death by coronary occlusion. We report a child with symptoms of embolization to the right kidney and the femoral artery, and a mobile mass in the left atrium attached to the mitral valve. Upon surgical removal, histopathology revealed IMT. Our case illustrates a unique presentation of systemic thromboembolism.
No takes yet. Share an insight, caveat, or question.
Vijayakumar et al. (2021) conducted a case report in Inflammatory myofibroblastic tumor of the mitral valve (n=1). Surgical removal was evaluated on Histopathology diagnosis. Surgical removal of a mobile left atrial mass attached to the mitral valve in a child with systemic thromboembolism revealed an inflammatory myofibroblastic tumor on histopathology.
Synapse has enriched 10 related papers. Consider them for comparative context: